Literature DB >> 11050193

Channel structure and drug-induced cardiac arrhythmias.

R S Kass1, C Cabo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050193      PMCID: PMC34333          DOI: 10.1073/pnas.97.22.11683

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  27 in total

1.  Molecular diagnosis and treatment of cardiovascular diseases.

Authors:  H J Duff
Journal:  Can J Cardiol       Date:  2000-03       Impact factor: 5.223

Review 2.  From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.

Authors:  W A Catterall
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

Review 3.  Congenital and acquired long QT syndrome.

Authors:  A J Camm; M J Janse; D M Roden; M R Rosen; J Cinca; S M Cobbe
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

Review 4.  Long QT syndromes and torsade de pointes.

Authors:  S Viskin
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

5.  A common polymorphism associated with antibiotic-induced cardiac arrhythmia.

Authors:  F Sesti; G W Abbott; J Wei; K T Murray; S Saksena; P J Schwartz; S G Priori; D M Roden; A L George; S A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

6.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

7.  Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias.

Authors:  C Napolitano; P J Schwartz; A M Brown; E Ronchetti; L Bianchi; A Pinnavaia; G Acquaro; S G Priori
Journal:  J Cardiovasc Electrophysiol       Date:  2000-06

8.  Long QT syndrome: ionic basis and arrhythmia mechanism in long QT syndrome type 1.

Authors:  M C Sanguinetti
Journal:  J Cardiovasc Electrophysiol       Date:  2000-06

9.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors:  G X Yan; C Antzelevitch
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

10.  Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate.

Authors:  J S Mitcheson; J Chen; M C Sanguinetti
Journal:  J Gen Physiol       Date:  2000-03       Impact factor: 4.086

View more
  6 in total

1.  Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.

Authors:  I Jeong; B H Choi; S J Hahn
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

2.  Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.

Authors:  Imju Jeong; Bok Hee Choi; Sang June Hahn
Journal:  Pflugers Arch       Date:  2010-08-24       Impact factor: 3.657

3.  Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.

Authors:  Hee Jae Kim; Hye Sook Ahn; Bok Hee Choi; Sang June Hahn
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-09       Impact factor: 4.249

4.  Pergolide block of the cloned Kv1.5 potassium channels.

Authors:  Imju Jeong; Bok Hee Choi; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-05       Impact factor: 3.000

5.  Escitalopram block of hERG potassium channels.

Authors:  Yun Ju Chae; Ji Hyun Jeon; Hong Joon Lee; In-Beom Kim; Jin-Sung Choi; Ki-Wug Sung; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-18       Impact factor: 3.000

6.  Nitric oxide-dependent modulation of the delayed rectifier K+ current and the L-type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes.

Authors:  Chang-Xi Bai; Kentaro Takahashi; Haruko Masumiya; Tohru Sawanobori; Tetsushi Furukawa
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.